132 related articles for article (PubMed ID: 21359415)
41. Large-cell medulloblastoma with arrestin-like protein expression.
Vincent S; Mirshari M; Nicolas C; Adenis C; Dhellemmes P; Soto Ares G; Maurage CA; Baranzelli MC; Giangaspero F; Ruchoux MM
Clin Neuropathol; 2003; 22(1):1-9. PubMed ID: 12617187
[TBL] [Abstract][Full Text] [Related]
42. Gene expression profiling using nanostring digital RNA counting to identify potential target antigens for melanoma immunotherapy.
Beard RE; Abate-Daga D; Rosati SF; Zheng Z; Wunderlich JR; Rosenberg SA; Morgan RA
Clin Cancer Res; 2013 Sep; 19(18):4941-50. PubMed ID: 24021875
[TBL] [Abstract][Full Text] [Related]
43. [Chromosome 17 abnormalities in medulloblastomas and their prognostic value].
Korshunov AG; Sycheva RV; Gorelyshev SK; Ozerov SS; Golanov AV
Zh Vopr Neirokhir Im N N Burdenko; 2008; (2):3-5; discussion 5. PubMed ID: 18724421
[TBL] [Abstract][Full Text] [Related]
44. Cerebellar stem cells act as medulloblastoma-initiating cells in a mouse model and a neural stem cell signature characterizes a subset of human medulloblastomas.
Sutter R; Shakhova O; Bhagat H; Behesti H; Sutter C; Penkar S; Santuccione A; Bernays R; Heppner FL; Schüller U; Grotzer M; Moch H; Schraml P; Marino S
Oncogene; 2010 Mar; 29(12):1845-56. PubMed ID: 20062081
[TBL] [Abstract][Full Text] [Related]
45. Childhood Medulloblastoma: An Overview.
Suk Y; Gwynne WD; Burns I; Venugopal C; Singh SK
Methods Mol Biol; 2022; 2423():1-12. PubMed ID: 34978683
[TBL] [Abstract][Full Text] [Related]
46. C-kit expression and mutational analysis in medulloblastoma.
Chilton-Macneill S; Ho M; Hawkins C; Gassas A; Zielenska M; Baruchel S
Pediatr Dev Pathol; 2004; 7(5):493-8. PubMed ID: 15547773
[TBL] [Abstract][Full Text] [Related]
47. Quantitative monitoring of the PRAME gene for the detection of minimal residual disease in leukaemia.
Matsushita M; Ikeda H; Kizaki M; Okamoto S; Ogasawara M; Ikeda Y; Kawakami Y
Br J Haematol; 2001 Mar; 112(4):916-26. PubMed ID: 11298586
[TBL] [Abstract][Full Text] [Related]
48. Quantitative assessment of PRAME expression in diagnosis of childhood acute leukemia.
Spanaki A; Perdikogianni C; Linardakis E; Kalmanti M
Leuk Res; 2007 May; 31(5):639-42. PubMed ID: 16860864
[TBL] [Abstract][Full Text] [Related]
49. MDM2 overexpression is associated with short survival in adults with medulloblastoma.
Giordana MT; Duó D; Gasverde S; Trevisan E; Boghi A; Morra I; Pradotto L; Mauro A; Chió A
Neuro Oncol; 2002 Apr; 4(2):115-22. PubMed ID: 11916503
[TBL] [Abstract][Full Text] [Related]
50. PRAME Gene Copy Number Variation Is Related to Its Expression in Multiple Myeloma.
Yang L; Wang YZ; Zhu HH; Chang Y; Li LD; Chen WM; Long LY; Zhang YH; Liu YR; Lu J; Qin YZ
DNA Cell Biol; 2017 Dec; 36(12):1099-1107. PubMed ID: 28953414
[TBL] [Abstract][Full Text] [Related]
51. PRAME expression and clinical outcome of breast cancer.
Epping MT; Hart AA; Glas AM; Krijgsman O; Bernards R
Br J Cancer; 2008 Aug; 99(3):398-403. PubMed ID: 18648365
[TBL] [Abstract][Full Text] [Related]
52. The relevance of preferentially expressed antigen of melanoma (PRAME) as a marker of disease activity and prognosis in acute promyelocytic leukemia.
Santamaría C; Chillón MC; García-Sanz R; Balanzategui A; Sarasquete ME; Alcoceba M; Ramos F; Bernal T; Queizán JA; Peñarrubia MJ; Giraldo P; San Miguel JF; Gonzalez M
Haematologica; 2008 Dec; 93(12):1797-805. PubMed ID: 18815192
[TBL] [Abstract][Full Text] [Related]
53. Differential Expression of microRNAs in Medulloblastoma and the Potential Functional Consequences.
Zhang Y; Li L; Liang P; Zhai X; Li Y; Zhou Y
Turk Neurosurg; 2018; 28(2):179-185. PubMed ID: 28481393
[TBL] [Abstract][Full Text] [Related]
54. Enhanced expression of DNA topoisomerase II genes in human medulloblastoma and its possible association with etoposide sensitivity.
Uesaka T; Shono T; Kuga D; Suzuki SO; Niiro H; Miyamoto K; Matsumoto K; Mizoguchi M; Ohta M; Iwaki T; Sasaki T
J Neurooncol; 2007 Sep; 84(2):119-29. PubMed ID: 17361331
[TBL] [Abstract][Full Text] [Related]
55. Oncogenic role of cytomegalovirus in medulloblastoma?
Hortal AM; Vermeulen JF; Van Hecke W; Bovenschen N
Cancer Lett; 2017 Nov; 408():55-59. PubMed ID: 28844716
[TBL] [Abstract][Full Text] [Related]
56. Tumor-associated antigen preferentially expressed antigen of melanoma (PRAME) induces caspase-independent cell death in vitro and reduces tumorigenicity in vivo.
Tajeddine N; Gala JL; Louis M; Van Schoor M; Tombal B; Gailly P
Cancer Res; 2005 Aug; 65(16):7348-55. PubMed ID: 16103086
[TBL] [Abstract][Full Text] [Related]
57. Prevalence and prognostic and predictive relevance of PRAME in breast cancer.
Doolan P; Clynes M; Kennedy S; Mehta JP; Crown J; O'Driscoll L
Breast Cancer Res Treat; 2008 May; 109(2):359-65. PubMed ID: 17624586
[TBL] [Abstract][Full Text] [Related]
58. Differential expression of survivin splice isoforms in medulloblastomas.
Li XN; Shu Q; Su JM; Adesina AM; Wong KK; Perlaky L; Antalffy BA; Blaney SM; Lau CC
Neuropathol Appl Neurobiol; 2007 Feb; 33(1):67-76. PubMed ID: 17239009
[TBL] [Abstract][Full Text] [Related]
59. PRAME is a membrane and cytoplasmic protein aberrantly expressed in chronic lymphocytic leukemia and mantle cell lymphoma.
Proto-Siqueira R; Figueiredo-Pontes LL; Panepucci RA; Garcia AB; Rizzatti EG; Nascimento FM; Ishikawa HC; Larson RE; Falcão RP; Simpson AJ; Gout I; Filonenko V; Rego EM; Zago MA
Leuk Res; 2006 Nov; 30(11):1333-9. PubMed ID: 16620968
[TBL] [Abstract][Full Text] [Related]
60. EZH2-regulated DAB2IP is a medulloblastoma tumor suppressor and a positive marker for survival.
Smits M; van Rijn S; Hulleman E; Biesmans D; van Vuurden DG; Kool M; Haberler C; Aronica E; Vandertop WP; Noske DP; Würdinger T
Clin Cancer Res; 2012 Aug; 18(15):4048-58. PubMed ID: 22696229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
